Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015

With the introduction of Medicare Access and CHIP (Children's Health Insurance Program) Reauthorization Act (MACRA), the yearly discussions about how to manage the legislated Medicare cuts from the sustainable growth rate are over.1 MACRA introduces 2 new reimbursement models: the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs), which are each discussed in detail in respective articles in this issue. Starting in 2017, all clinicians who provide Medicare part B services must choose between these 2 reimbursement models.

http://ift.tt/2mUokYr